Heron Therapeutics reported $89.59M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
ALKERMES USD 459.09M 2.61M Sep/2026
Alnylam Pharmaceuticals USD 1.08B 172.17M Sep/2026
Amarin USD 126.83M 477K Dec/2025
ANI Pharmaceuticals USD 304.45M 29.98M Sep/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 8.56M 7.13M Jun/2026
Eisai JPY 237.44B 15.69B Sep/2026
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
GlaxoSmithKline GBP 8.52B 451M Sep/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Insmed USD 259.27M 43.94M Sep/2026
Ligand Pharmaceuticals USD 69.92M 15.12M Jun/2026
Merck USD 12.56B 354M Jun/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Neurocrine Biosciences USD 957.3M 70.3M Sep/2026
Omeros USD 8.08M 440K Jun/2024
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Ultragenyx Pharmaceutical USD 200M 140M Jun/2026
Veracyte USD 56.79M 2.61M Sep/2026
Vertex Pharmaceuticals USD 2.31B 176.7M Sep/2026